Artemis Medicare Services Share Price Today | Stock Price & Artemis Medicare Services Share Screener
As of October 5, 2026, the live Artemis Medicare Services share price (NSE: ARTEMISMED) is ₹324.10 on NSE and ₹323.80 on BSE, down 3.66% from the previous close, with shares trading between ₹322.35 and ₹341.85 in today's trading session, and a 52-week range of ₹205.51–₹366.60. Check ARTEMISMED annual price range for the annual price range and momentum. Use the Artemis Medicare Services stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Artemis Medicare Services opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹287 and net income of ₹30, with EBITDA of ₹59, an operating margin of 18.0% and a profit margin of 10.5%.
Artemis Medicare Services Share Price Chart
Track the current stock price of Artemis Medicare Services with an interactive chart. Analyse ARTEMISMED share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Artemis Medicare Services stock quote in one place.
The quote of ₹324.10 sits between the 52-week low of ₹205.51 and the 52-week high of ₹366.60, and the latest session moved -3.66% from the previous close.
Artemis Medicare Services Company Profile - Fundamental Screener
Screen Artemis Medicare Services company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ARTEMISMED shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Hospitals industry, and it trades under ISIN INE025R01021.
Company Details
Classification
Identifiers and Leadership
Artemis Medicare Services Balance Sheet Screener
Screen ARTEMISMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹1,429, up from ₹1,357 in 2025.
Latest statistics put total assets at ₹1,429 and shareholder funds at ₹941, with a leverage ratio of 0.34.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
Assets |
||||||||
| Total Assets | 1,429 | 1,357 | 972 | 905 | 710 | 600 | 586 | 554 |
| Current Assets | 367 | 535 | 180 | 170 | 127 | 110 | 118 | 113 |
| Fixed Assets | 804 | 745 | 719 | 605 | 489 | 383 | 393 | 381 |
Liabilities |
||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 277 | 298 | 332 | 292 | 210 | 160 | 115 | 84 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||
| Total Equity | 941 | 844 | 455 | 408 | 361 | 322 | 314 | 293 |
| Share Capital | 16 | 14 | 14 | 13 | 13 | 13 | 13 | 13 |
| Reserves & Surplus | 919 | 503 | 435 | 390 | 346 | 307 | 300 | 280 |
Artemis Medicare Services Income Statement Screener - Profit & Revenue Analysis
Screen Artemis Medicare Services income statement and profit fundamentals. Analyze ARTEMISMED quarterly results. Artemis Medicare Services reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹287 and net profit was ₹30, equal to earnings per unit of ₹1.90, at an operating margin of 18%.
In that period expenses were ₹228, interest cost ₹6 and tax ₹10. The next period listed, 2026-Jun, shows revenue of ₹293 and net profit of ₹31.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 287 | 293 | 252 | 262 | 282 | 280 | 227 | 228 | 249 | 241 | 198 | 211 | 227 | 221 | 151 |
| Expenses | 228 | 231 | 204 | 214 | 224 | 231 | 187 | 187 | 199 | 195 | 170 | 182 | 191 | 186 | 132 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 59 | 62 | 48 | 48 | 58 | 49 | 40 | 41 | 50 | 46 | 28 | 29 | 37 | 34 | 18 |
| Operating Profit % | 18.00% | 20.00% | 15.00% | 16.00% | 18.00% | 15.00% | 17.00% | 16.00% | 18.00% | 16.00% | 13.00% | 13.00% | 15.00% | 15.00% | 11.00% |
| Depreciation | 13 | 13 | 12 | 11 | 12 | 12 | 11 | 11 | 11 | 11 | 9 | 9 | 10 | 10 | 6 |
| Interest | 6 | 7 | 8 | 7 | 7 | 7 | 9 | 8 | 8 | 8 | 5 | 7 | 8 | 8 | 4 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 40 | 43 | 29 | 30 | 39 | 30 | 20 | 22 | 31 | 27 | 14 | 13 | 19 | 16 | 8 |
| Tax | 10 | 11 | 6 | 9 | 9 | 8 | 6 | 5 | 8 | 6 | 3 | 3 | 5 | 5 | -5 |
| Net Profit | 30 | 31 | 23 | 21 | 30 | 22 | 14 | 17 | 22 | 21 | 11 | 10 | 14 | 12 | 13 |
| EPS | 1.90 | 1.98 | 1.47 | 1.35 | 1.90 | 1.41 | 1.04 | 1.14 | 1.42 | 1.32 | 0.79 | 0.72 | 1.00 | 0.85 | 1.00 |
Artemis Medicare Services Cash Flow Screener - Liquidity Fundamentals
Screen ARTEMISMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹132, and net cash flow was an outflow of ₹8.
Over the same period, investing activities used ₹90 and financing activities used ₹50.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||
| Operating Activities | 132 | 156 | 109 | 127 | 60 | 27 | 56 | 41 |
| Investing Activities | -90 | -393 | -88 | -158 | -107 | -37 | -26 | -50 |
Financing and Net Cash | ||||||||
| Financing Activities | -50 | 265 | -29 | 38 | 44 | 18 | -27 | 14 |
| Net Cash Flow | -8 | 27 | -8 | 7 | -4 | 8 | 2 | 5 |
Artemis Medicare Services Shareholding Pattern Screener
See Artemis Medicare Services shareholding pattern with promoter, FII, and DII holdings. Check Artemis Medicare Services promoter holding and ownership changes for ARTEMISMED on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 58.39%, foreign institutions 12.19%, domestic institutions 2.89% and the public 12.36%, spread across 32,044 shareholders.
The shareholder count was 32,044 in 2026-Mar, compared with 36,335 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Nov | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 58.39% | 58.39% | 67.17% | 66.53% | 66.53% | 58.43% | 58.39% | 68.03% |
Institutional Investors | ||||||||
| FII Holding | 12.19% | 12.29% | 0.31% | 0.24% | 0.37% | 12.48% | 12.47% | 0.10% |
| DII Holding | 2.89% | 2.40% | 5.04% | 4.76% | 4.27% | 3.35% | 2.91% | 2.61% |
Government, Public and Others | ||||||||
| Govt Holding | 6.16% | 6.16% | 7.09% | 7.02% | 7.02% | 6.16% | 6.16% | 7.18% |
| Public Holding | 12.36% | 12.79% | 12.86% | 12.93% | 13.44% | 11.65% | 12.12% | 14.74% |
| Other Holding | 8.01% | 7.97% | 7.53% | 8.52% | 8.37% | 7.93% | 7.96% | 7.34% |
| Shareholder Count | 32,044 | 36,335 | 28,397 | 31,614 | 33,559 | 31,884 | 31,602 | 19,993 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Artemis Medicare Services. Artemis Medicare Services dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.45 per unit for 2026-March, a yield of 0.13%, compared with ₹0.45 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.45, ₹0.45 and ₹0.45 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.45 | 0.13% |
| 2025-March | ₹0.45 | 0.22% |
| 2024-March | ₹0.45 | 0.16% |
| 2023-March | ₹0.45 | 0.26% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Artemis Medicare Services Stock Index Membership - Nifty & Sensex
See which indices include Artemis Medicare Services stock. Check ARTEMISMED index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 2 indices, including BSE INDEX BSE HC.
Among the benchmarks tracked are BSE INDEX BSE HC, BSE INDEX SMLCAP.
Complete Index List
Artemis Medicare Services Market Events Screener - Corporate Actions
Get Artemis Medicare Services corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Artemis Medicare Services stock events that may affect ARTEMISMED share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 3, 2026, with a record date of August 3, 2026.
It is followed by Annual General Meeting dated July 31, 2026 and Dividend dated July 10, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-03 | 2026-08-03 | Quarterly Result Announcement | NA | 7.68% |
| 2026-07-31 | 2026-07-31 | Annual General Meeting | NA | 17.28% |
| 2026-07-10 | 2026-07-10 | Dividend | ₹ 0.45 /share | 0.71% |
| 2026-05-08 | 2026-05-08 | Quarterly Result Announcement | NA | 6.53% |
| 2026-02-02 | 2026-02-02 | Quarterly Result Announcement | NA | 5.62% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 0.02% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | 6.20% |
| 2025-07-30 | 2025-07-30 | Annual General Meeting | NA | -3.97% |
| 2025-07-11 | 2025-07-11 | Dividend | ₹ 0.45 /share | 5.08% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | -8.22% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | 2.93% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -1.84% |
| 2024-07-24 | 2024-07-24 | Annual General Meeting | NA | 23.92% |
| 2024-07-05 | 2024-07-05 | Dividend | ₹ 0.45 /share | -4.82% |
| 2024-05-03 | 2024-05-03 | Extraordinary General Meeting | NA | -2.08% |
Artemis Medicare Services Competitors Screener - Peer Stocks Comparison
Screen ARTEMISMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 124,503 | 58.67 | 25,420 | 15.58% | 2,003 | 43.13 |
| Max Healthcare Institute | 95,582 | 66.86 | 8,536 | 18.82% | 1,442 | 36.74 |
| Aster DM Quality Care | 63,976 | 179.76 | 4,769 | 11.25% | 427 | 36.84 |
| Fortis Healthcare | 62,058 | 58.65 | 9,179 | 16.93% | 1,064 | 25.57 |
| Global Health | 38,047 | 69.81 | 4,509 | 19.56% | 554 | 44.47 |
| Narayana Hrudayalaya | 36,579 | 45.50 | 7,996 | 43.43% | 811 | 38.14 |
| Krishna Institute of Medical Sciences | 32,336 | 165.49 | 3,931 | 28.16% | 242 | 45.36 |
| Dr. Agarwal's Health Care | 15,699 | 86.39 | 2,125 | 20.92% | 168 | 44.18 |
| Rainbow Childrens Medicare | 13,891 | 48.05 | 1,747 | 11.49% | 282 | 31.72 |
| Park Medi World | 11,898 | 40.25 | 1,711 | 19.99% | 274 | 41.32 |
Artemis Medicare Services Company Announcements - News & Reports Screener
Screen ARTEMISMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated September 22, 2026.
The next most recent announcements are dated September 8, 2026 and August 27, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-09-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-03 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-08-03 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-03 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-03 | Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-03 | Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2026 | - |
| 2026-08-03 | Board Meeting Outcome for Board Meeting Held On August 3 2026 | - |
| 2026-08-03 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-07-31 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
| 2026-07-31 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-07-31 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-07-31 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-07-29 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-29 | Board Meeting Intimation for Consideration Of Un-Audited Financial Results | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹324.10, within a 52-week range of ₹205.51 to ₹366.60. The P/E ratio is 50.69 and the P/B ratio is 6.67, with earnings per unit of ₹6.56. Market capitalisation stands at ₹5,803.51 Cr and the dividend yield is 0.12%. The company operates in the Healthcare Services sector, in the Hospitals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on September 29, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.